Gene · 51129
Papers4,105
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 4,105
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Keratinocyte-specific long non-coding RNA NR037661 controls alternative splicing of ANGPTL4 to induce keratinocyte differentiation. | Noncoding RNA Res | 2026 | 41245814 | PubTator, text mining | PubMed |
| Pemafibrate Increases Circulating Angiopoietin-like Proteins 3 and 4 Without Promoting Pro-Atherogenic Changes in LDL and HDL Subspecies: A Post-Hoc Analysis of the PRESTIGE Study. | J Atheroscler Thromb | 2026 | 41047339 | PubTator, text mining | PubMed |
| Mono(2-Ethylhexyl) Phthalate Induces Inflammatory and Angiogenic Alterations Mediated by the PI3K/AKT Pathway in HTR-8/SVneo Trophoblastic Cells. | Environ Toxicol | 2026 | 41001692 | PubTator, text mining | PubMed |
Phase 1 dose-escalation trial of sub-endometrial injection of human embryonic stem cells-derived immunity-and-matrix-regulatory cells to promote endometrial angiogenesis in refractory intrauterine adhesion. | Mol Ther | 2026 | 40988336 | PubTator, text mining | PubMed |
| Macrophage migration inhibitory factor and angiopoietin-like protein 4 as markers for steroid response in children with idiopathic nephrotic syndrome. | Pediatr Nephrol | 2026 | 40968277 | PubTator, text mining | PubMed |
| Hsa_circ_0005623 is an indicator for pulmonary artery hypertension associated with congenital heart disease. | Front Cardiovasc Med | 2025 | 41602344 | PubTator, text mining | PubMed |
| Exploring rare coding variants in UK biobank: preliminary associations with motor neuron disease. | Front Aging Neurosci | 2025 | 41583004 | PubTator, text mining | PubMed |
| First look at evaluation of serum angiopoietin-like 4 levels in bladder cancer: A pilot study. | J Physiol Pharmacol | 2025 | 41569057 | PubTator, text mining | PubMed |
| Identification of immune-related prognostic biomarkers in lung squamous cell carcinoma microenvironment. | Front Immunol | 2025 | 41562084 | PubTator, text mining | PubMed |
| Impact of Bariatric Surgery Type on Adipokines, Myokines, and Hepatokines: An 18-Month Prospective, Observational, Open-Label Study. | Physiol Res | 2025 | 41511104 | PubTator, text mining | PubMed |
| A lactylation-driven prognostic model for lung adenocarcinoma: cellular lactylation heterogeneity and immune insights. | Transl Lung Cancer Res | 2025 | 41510385 | PubTator, text mining | PubMed |
| Systemic angiogenic protein changes following propranolol therapy in infantile hemangioma: a multi-target perspective. | Front Pharmacol | 2025 | 41487524 | PubTator, text mining | PubMed |
| Targeting OxLDL-mediated CD36 + CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma. | Mol Cancer | 2025 | 41413558 | PubTator, text mining | PubMed |
| Hypertriglyceridaemia and elevated cardiovascular risk: will ANGPTL4 inhibition address both? | Cardiovasc Res | 2025 | 41411295 | PubTator, text mining | PubMed |
| WITHDRAWN: Multi-omics integration deciphers immune-metabolic heterogeneity in CRC: A prognostic model and therapeutic strategies targeting ANGPTL4/FABP4/RBP7. | Comput Biol Med | 2025 | 41381279 | PubTator, text mining | PubMed |
| Saliva from oral squamous cell carcinoma patients promotes tumor progression via Inflammation, stromal remodeling, and metabolic reprogramming in a mouse model. | BMC Oral Health | 2025 | 41327157 | PubTator, text mining | PubMed |
| From Single-Cell Atlas to Functional Validation: Critical Next Steps for Understanding Tip Cell-Mediated Communication in the Injured Spinal Cord. | J Cell Physiol | 2025 | 41288006 | PubTator, text mining | PubMed |
| ANGPTL4 overexpression is associated with progression and poor prognoses of olfactory neuroblastoma. | Diagn Pathol | 2025 | 41286937 | PubTator, text mining | PubMed |
| Lineage plasticity and signal dysregulation define the cellular trajectory of osteoarthritis progression. | Clin Exp Med | 2025 | 41286526 | PubTator, text mining | PubMed |
| Increased Serum Angiopoietin-like Peptide 4 in Impaired Glucose Tolerance and Diabetes Subjects with or Without Hepatic Steatosis. | J Clin Med | 2025 | 41226996 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51129/papers?page=8